Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCY

Preclinical and clinical evaluation of the effect on oral administration of MANITHAKKALI ENNAI in the management of AKKARA MANTHAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/039956

Enrollment

Registered

2022-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E539- Vitamin B deficiency, unspecified

Interventions

Intervention1: MANITHAKKALI ENNAI: should be administrated orally twice a day after day for a period of 21 days dose :1ml Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Lips eruption and cracks 2.Redness of tongue 3.Loss of appetite 4.Fever 5.Fever with chills 6.Diarrhoea 7.Nausea and vomiting

Exclusion criteria

Exclusion criteria: 1.Children above 12 years 2.Children below 3 years 3.High grade fever more than 100degree fahrenheit 4.Oral candidiasis (oral thrush) 5.Leukoplakia 6.Severe avitaminosis

Design outcomes

Primary

Measure	Time frame
Reducing in clinical symptomsTimepoint: Reducing in clinical symptoms 21 days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr D K SOUNDARARAJAN MD S

Government Siddha Medical College and Hospital, Palayamkottai.

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026